INSULET CORPORATION
NASDAQ: PODD (Insulet Corporation)
Kemas kini terakhir: 20 jam lalu266.30
9.45 (3.68%)
Penutupan Terdahulu | 256.85 |
Buka | 258.00 |
Jumlah Dagangan | 416,999 |
Purata Dagangan (3B) | 545,139 |
Modal Pasaran | 18,679,560,192 |
Harga / Pendapatan (P/E TTM) | 45.44 |
Harga / Pendapatan (P/E Ke hadapan) | 66.23 |
Harga / Jualan (P/S) | 9.89 |
Harga / Buku (P/B) | 16.12 |
Julat 52 Minggu | |
Tarikh Pendapatan | 20 Feb 2025 - 24 Feb 2025 |
Margin Keuntungan | 21.22% |
Margin Operasi (TTM) | 16.20% |
EPS Cair (TTM) | 5.88 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 25.70% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | 49.30% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 128.91% |
Nisbah Semasa (MRQ) | 3.68 |
Aliran Tunai Operasi (OCF TTM) | 327.80 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 106.08 M |
Pulangan Atas Aset (ROA TTM) | 7.57% |
Pulangan Atas Ekuiti (ROE TTM) | 48.79% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Devices (US) | Bercampur | Bercampur |
Medical Devices (Global) | Bercampur | Bercampur | |
Stok | Insulet Corporation | Menaik | Menaik |
AISkor Stockmoo
Konsensus Penganalisis | 1.5 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -0.5 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | -0.5 |
Purata | 0.13 |
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide. |
|
Sektor | Healthcare |
Industri | Medical Devices |
Gaya Pelaburan | Mid Growth |
% Dimiliki oleh Orang Dalam | 0.33% |
% Dimiliki oleh Institusi | 103.25% |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 330.00 (JP Morgan, 23.92%) | Beli |
Median | 304.50 (14.35%) | |
Rendah | 234.00 (Barclays, -12.13%) | Pegang |
Purata | 295.40 (10.93%) | |
Jumlah | 9 Beli, 1 Pegang | |
Harga Purata @ Panggilan | 264.13 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
TD Cowen | 03 Jan 2025 | 324.00 (21.67%) | Beli | 266.30 |
JP Morgan | 12 Dec 2024 | 330.00 (23.92%) | Beli | 271.73 |
Citigroup | 11 Dec 2024 | 310.00 (16.41%) | Beli | 273.47 |
Wells Fargo | 11 Dec 2024 | 305.00 (14.53%) | Beli | 273.47 |
Canaccord Genuity | 09 Dec 2024 | 304.00 (14.16%) | Beli | 265.12 |
Barclays | 11 Nov 2024 | 234.00 (-12.13%) | Pegang | 275.70 |
Morgan Stanley | 11 Nov 2024 | 317.00 (19.04%) | Beli | 275.70 |
BTIG | 08 Nov 2024 | 270.00 (1.39%) | Beli | 268.00 |
14 Oct 2024 | 260.00 (-2.37%) | Beli | 232.51 | |
Bernstein | 06 Nov 2024 | 300.00 (12.65%) | Beli | 239.30 |
Raymond James | 14 Oct 2024 | 260.00 (-2.37%) | Beli | 232.51 |
Papar semua |
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
04 Dec 2024 | Pengumuman | Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court |
20 Nov 2024 | Pengumuman | Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S. |
15 Nov 2024 | Pengumuman | Insulet to Present at Upcoming Investor Conferences |
07 Nov 2024 | Pengumuman | Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency¹) |
01 Nov 2024 | Pengumuman | Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November |
29 Oct 2024 | Pengumuman | Omnipod® 5 App for iPhone® Now Fully Available in the United States |
10 Oct 2024 | Pengumuman | National Campaign Launches to Combat Diabetes Stigma Using Comedy |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |